XML 61 R43.htm IDEA: XBRL DOCUMENT
v3.25.1

COMMON STOCK OPTIONS AND WARRANTS (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract] |
Schedule of options activity |
Schedule of options activity |  |  |  |  |  |  |  |  |  |  |  |  |
|  |  | Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value |
| Outstanding at December 31, 2022 |  |  |  | 926,266 |  |  | $ | 5.74 |  |  |  | 3.3 |  |  | $ | — |
| Granted |  |  |  | 463,117 |  |  | $ | 4.22 |  |  |  | 4.35 |  |  |  | — |
| Forfeited |  |  |  | (1,608 | ) |  | $ | 14.00 |  |  |  | — |  |  |  | — |
| Outstanding at December 31, 2023 |  |  |  | 1,387,775 |  |  | $ | 5.23 |  |  |  | 3.0 |  |  |  | — |
| Exercisable at December 31, 2023 |  |  |  | 581,324 |  |  | $ | 5.38 |  |  |  | 1.8 |  |  | $ | — |
| Outstanding at December 31, 2023 |  |  |  | 1,387,775 |  |  | $ | 5.23 |  |  |  | 3.0 |  |  | $ | — |
| Granted |  |  |  | — |  |  | $ | — |  |  |  | — |  |  |  | — |
| Forfeited |  |  |  | (781,323 | ) |  | $ | 5.17 |  |  |  | — |  |  |  | — |
| Outstanding at December 31, 2024 |  |  |  | 606,452 |  |  | $ | 5.29 |  |  |  | 2.0 |  |  | $ | 514,394 |
| Exercisable at December 31, 2024 |  |  |  | 442,445 |  |  | $ | 5.50 |  |  |  | 1.6 |  |  | $ | 296,145 |
Schedule of weighted- average assumptions |
Schedule of weighted- average assumptions |  |  |  |  |  |
|  | For the Years Ended December 31, |
|  | 2024 |  |  | 2023 |
Risk free interest rate |  |  | — |  |  |  | 3.73 | %
Expected term in years |  |  | — |  |  |  | 3.50 |
Dividend yield |  |  | — |  |  |  | — |
Volatility of common stock |  |  | — |  |  |  | 54% – 118% |
Weighted average grant date fair value per option |  | $ | — |  |  | $ | 1.57 |
Schedule of warrants outstanding |
Schedule of warrants outstanding |  |  |  |  |  |  |  |  |  |  |  |
|  | Number of Warrants |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value |
Outstanding at December 31, 2022 |  |  | 80,091 |  |  | $ | 8.63 |  |  |  | 0.8 |  |  |  | — |
Warrants expired, forfeited, cancelled or exercised |  |  | (102,947 | ) |  | $ | — |  |  |  | — |  |  |  | — |
Warrants issued |  |  | — |  |  | $ | — |  |  |  | — |  |  |  | — |
Outstanding at December 31, 2023 |  |  | 44,644 |  |  | $ | 7.70 |  |  |  | 0.7 |  |  |  | — |
Exercisable at December 31, 2023 |  |  | 44,644 |  |  | $ | 7.70 |  |  |  | 0.7 |  |  |  | — |
Outstanding at December 31, 2023 |  |  | 44,644 |  |  | $ | 7.70 |  |  |  | 0.7 |  |  |  | — |
Warrants expired, forfeited, cancelled or exercised |  |  | (344,644 | ) |  | $ | — |  |  |  | — |  |  |  | — |
Warrants issued |  |  | 300,000 |  |  | $ | 3.00 |  |  |  | 4.47 |  |  |  | — |
Outstanding at December 31, 2024 |  |  | — |  |  | $ | — |  |  |  | — |  |  |  | — |
Exercisable at December 31, 2024 |  |  | — |  |  | $ | — |  |  |  | — |  |  |  | — |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration